HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu-Kyong Shin Selected Research

Blood Glucose (Blood Sugar)

1/2008Bitter taste receptors influence glucose homeostasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu-Kyong Shin Research Topics

Disease

3Inflammation (Inflammations)
10/2023 - 06/2018
3Body Weight (Weight, Body)
01/2023 - 05/2010
3Type 2 Diabetes Mellitus (MODY)
10/2013 - 01/2008
2Obesity
01/2023 - 01/2022
2Infections
02/2006 - 10/2005
1Colitis
07/2023
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
07/2023
1Dysbiosis
01/2023
1Overweight
01/2022
1Hyperlipidemias (Hyperlipidemia)
03/2021
1Alveolar Bone Loss
06/2018
1Periodontitis
06/2018
1Wounds and Injuries (Trauma)
01/2018
1Immune System Diseases (Immune Disorders)
02/2017
1Prediabetic State (Prediabetes)
10/2013
1Insulin Resistance
10/2013
1Weight Gain
10/2013
1Bites and Stings (Sting)
06/2009
1Hyperglycemia
06/2009
1Metabolic Diseases (Metabolic Disease)
01/2008

Drug/Important Bio-Agent (IBA)

3Insulin (Novolin)FDA Link
03/2021 - 01/2008
3Glucose (Dextrose)FDA LinkGeneric
10/2013 - 01/2008
2Ethanol (Ethyl Alcohol)IBA
10/2023 - 01/2023
2Sirtuin 1IBA
01/2023 - 10/2013
2Hormones (Hormone)IBA
03/2021 - 05/2010
2Proteins (Proteins, Gene)FDA Link
02/2006 - 10/2005
1Air Pollutants (Pollutants, Air)IBA
10/2023
1Particulate MatterIBA
10/2023
1sodium sulfate (sodium bisulfate)FDA LinkGeneric
07/2023
1hydrangenolIBA
07/2023
1Dextrans (Dextran)FDA Link
07/2023
1Dextran SulfateIBA
07/2023
1Tight Junction ProteinsIBA
07/2023
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2023
1Electron Transport Complex IV (Cytochrome c Oxidase)IBA
01/2023
1TabletsIBA
01/2022
1Anti-Obesity Agents (Antiobesity Drugs)IBA
01/2022
1CholesterolIBA
03/2021
1LeptinIBA
03/2021
1LipidsIBA
03/2021
1LDL Lipoproteins (beta Lipoproteins)IBA
03/2021
1oxidized low density lipoproteinIBA
03/2021
1Biomarkers (Surrogate Marker)IBA
06/2018
1trachelosideIBA
01/2018
1Therapeutic UsesIBA
02/2017
1SugarsIBA
10/2013
1ResveratrolIBA
10/2013
1Acetaminophen (Paracetamol)FDA LinkGeneric
06/2009
1Saline SolutionIBA
06/2009
1Peptides (Polypeptides)IBA
06/2009
1gastric inhibitory polypeptide receptorIBA
06/2009
1Glucagon-Like Peptide 1 (GLP 1)IBA
06/2009
1Glucagon-Like Peptides (Enteroglucagon)IBA
06/2009
1Blood Glucose (Blood Sugar)IBA
01/2008

Therapy/Procedure

5Oral Administration
07/2023 - 06/2018
1Therapeutics
07/2023
1Ligation
06/2018